Scarica l'app Stockscreener
4.86
3.76%
-0.19
Dopo l'orario di chiusura:
4.86
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Form 13D/A LIFECORE BIOMEDICAL For: 2 July By Investing.com - Investing.com India
Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026 - TradingView
Lifecore Biomedical (NASDAQ: LFCR) gets $52.1M preferred redemption requests - Stock Titan
[SCHEDULE 13D/A] LIFECORE BIOMEDICAL, INC. \DE\ Amended Major Shareholder Report - Stock Titan
(LFCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? - Yahoo Finance
Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - simplywall.st
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review
12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey
Enterprise value to revenue forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to sales forward of Lifecore Biomedical, Inc. – SWB:LDE - TradingView
Price to book forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to sales forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (NASDAQ:LFCR) - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biom - The National Law Review
Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Price to earnings forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (GETTEX:LDE) - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView
LFCR Forecast — Price Target — Prediction for 2027 - TradingView
LDE Forecast — Price Target — Prediction for 2027 - TradingView
LFCR Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesEnergy Earnings Report - dars.gov.et
How (LFCR) Movements Inform Risk Allocation Models - Stock Traders Daily
LFCR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock Edges HigherAnnual Report - dars.gov.et
Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lifecore Biomedical Inc (LFCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lifecore Biomedical Inc (LFCR) Institutional Confidence - TradingKey
Lifecore Biomedical Inc (LFCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lifecore Biomedical Inc (LFCR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lifecore Biomedical Inc (LFCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lifecore Biomedical signs manufacturing deal for neurology product By Investing.com - Investing.com Nigeria
Lifecore Biomedical signs manufacturing deal for neurology product - Investing.com
Lifecore Biomedical Signs Agreement for Tech Transfer and Commercial Production of Neurological Injectable Product - Quiver Quantitative
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company - GlobeNewswire
LFCR Q1 2026 Earnings: Wider-than-Expected Loss Weighs on Investor SentimentPreliminary Results - newsline.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook - Yahoo Finance
Trading Systems Reacting to (LFCR) Volatility - Stock Traders Daily
Lifecore Biomedical (LFCR) director awarded 25,907 RSUs - Stock Titan
Lifecore Biomedical (LFCR) director receives 25,907-share restricted stock award - Stock Titan
Lifecore Biomedical (LFCR) director receives 25,907 restricted stock units - Stock Titan
Lifecore Biomedical (LFCR) director receives 25,907-share restricted stock unit grant - Stock Titan
Lifecore Shareholders Approve New 2026 Stock Incentive Plan - TipRanks
Lifecore Biomedical (NASDAQ: LFCR) wins approval for 2026 stock plan - Stock Titan
LFCR Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock Rises Despite WeaknessAnnual Financial Report - newsline.com
Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic - Contract Pharma
Lifecore Biomedical signs ophthalmic manufacturing deal - Investing.com UK
Lifecore Biomedical, Inc. Signs Manufacturing Services Agreement with Leading Provider of Ophthalmic Disease Management Solutions - marketscreener.com
Lifecore Biomedical signs ophthalmic manufacturing deal By Investing.com - Investing.com South Africa
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer - The Manila Times
Pre-filled ophthalmic injectables: Lifecore inks new manufacturing deal - Stock Titan
Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: EPS Misses Estimates by 75.6% as Revenue Remains UndisclosedBuyback Announcement Report - newsline.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile
Lifecore Biomedical (LFCR) Inches Higher as Stock Approaches Key ResistanceWyckoff Distribution - newsline.com
How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations - Yahoo Finance
LFCRLifecore Biomedical Inc Stock Price and Quote - Finviz
LFCR Q1 2026 Earnings: EPS Falls Short of Estimates as Losses WidenEarnings Season Outlook - The Legal Advocate
0.15%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):